End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-27 pm EDT
|
5-day change
|
1st Jan Change
|
12.14
CNY
|
+2.88%
|
|
+3.14%
|
-22.97%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,739
|
9,063
|
12,373
|
9,004
|
8,262
|
6,364
|
-
|
-
|
Enterprise Value (EV)
1 |
7,739
|
9,063
|
12,373
|
9,404
|
8,979
|
6,364
|
6,364
|
6,364
|
P/E ratio
|
29.9
x
|
39.5
x
|
32.2
x
|
20.4
x
|
75
x
|
14.9
x
|
15.2
x
|
13.3
x
|
Yield
|
-
|
0.37%
|
0.29%
|
0.47%
|
0.51%
|
0.66%
|
-
|
-
|
Capitalization / Revenue
|
5.11
x
|
4.86
x
|
4.71
x
|
3.1
x
|
3.03
x
|
1.93
x
|
1.74
x
|
1.47
x
|
EV / Revenue
|
5.11
x
|
4.86
x
|
4.71
x
|
3.1
x
|
3.03
x
|
1.93
x
|
1.74
x
|
1.47
x
|
EV / EBITDA
|
19.8
x
|
23.3
x
|
20.5
x
|
14
x
|
24.8
x
|
9.14
x
|
8.34
x
|
7.01
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3.21
x
|
3.47
x
|
3.93
x
|
2.56
x
|
2.17
x
|
1.51
x
|
1.41
x
|
1.29
x
|
Nbr of stocks (in thousands)
|
517,642
|
510,305
|
512,138
|
524,380
|
524,209
|
524,209
|
-
|
-
|
Reference price
2 |
14.95
|
17.76
|
24.16
|
17.17
|
15.76
|
12.14
|
12.14
|
12.14
|
Announcement Date
|
2/27/20
|
3/17/21
|
3/30/22
|
3/30/23
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,513
|
1,864
|
2,627
|
2,907
|
2,729
|
3,298
|
3,663
|
4,318
|
EBITDA
1 |
390.3
|
388.2
|
602.9
|
643.9
|
333.6
|
696.3
|
763.3
|
907.9
|
EBIT
1 |
305.8
|
275.9
|
478.3
|
495
|
151.4
|
492.2
|
574.3
|
654
|
Operating Margin
|
20.21%
|
14.8%
|
18.21%
|
17.03%
|
5.55%
|
14.92%
|
15.68%
|
15.15%
|
Earnings before Tax (EBT)
1 |
303.8
|
274.9
|
474.4
|
493.1
|
151.2
|
491.7
|
573.3
|
653
|
Net income
1 |
255.1
|
229.8
|
385.9
|
434.6
|
112.4
|
391.5
|
423.4
|
481.1
|
Net margin
|
16.86%
|
12.33%
|
14.69%
|
14.95%
|
4.12%
|
11.87%
|
11.56%
|
11.14%
|
EPS
2 |
0.5000
|
0.4500
|
0.7500
|
0.8400
|
0.2100
|
0.8167
|
0.8000
|
0.9100
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.0650
|
0.0700
|
0.0800
|
0.0800
|
0.0800
|
-
|
-
|
Announcement Date
|
2/27/20
|
3/17/21
|
3/30/22
|
3/30/23
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
400
|
717
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.6213
x
|
2.15
x
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
11.1%
|
9.03%
|
10.7%
|
12.7%
|
2.99%
|
10.1%
|
10.6%
|
10.9%
|
ROA (Net income/ Total Assets)
|
6.21%
|
4.48%
|
5.62%
|
-
|
-
|
6.1%
|
-
|
-
|
Assets
1 |
4,110
|
5,135
|
6,861
|
-
|
-
|
6,419
|
-
|
-
|
Book Value Per Share
2 |
4.660
|
5.120
|
6.150
|
6.720
|
7.250
|
8.070
|
8.590
|
9.420
|
Cash Flow per Share
2 |
0.3600
|
0.3300
|
0.5000
|
0.7600
|
0.5500
|
0.8100
|
1.020
|
0.7300
|
Capex
1 |
267
|
261
|
266
|
195
|
271
|
389
|
588
|
586
|
Capex / Sales
|
17.68%
|
14%
|
10.11%
|
6.7%
|
9.93%
|
11.79%
|
16.06%
|
13.58%
|
Announcement Date
|
2/27/20
|
3/17/21
|
3/30/22
|
3/30/23
|
4/28/24
|
-
|
-
|
-
|
Last Close Price
12.14
CNY Average target price
16.21
CNY Spread / Average Target +33.53% Consensus |
1st Jan change
|
Capi.
|
---|
| -22.97% | 854M | | +0.88% | 50B | | +21.10% | 42.94B | | +27.82% | 27.25B | | +9.54% | 19.34B | | -2.65% | 16.7B | | +7.54% | 16.1B | | -25.63% | 15.65B | | -11.57% | 15B | | -17.62% | 14.12B |
Other Specialty Chemicals
|